JP2025501764A5 - - Google Patents

Info

Publication number
JP2025501764A5
JP2025501764A5 JP2024538285A JP2024538285A JP2025501764A5 JP 2025501764 A5 JP2025501764 A5 JP 2025501764A5 JP 2024538285 A JP2024538285 A JP 2024538285A JP 2024538285 A JP2024538285 A JP 2024538285A JP 2025501764 A5 JP2025501764 A5 JP 2025501764A5
Authority
JP
Japan
Prior art keywords
acid
poly
glycero
lactic acid
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024538285A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025501764A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/053948 external-priority patent/WO2023122331A2/en
Publication of JP2025501764A publication Critical patent/JP2025501764A/ja
Publication of JP2025501764A5 publication Critical patent/JP2025501764A5/ja
Pending legal-status Critical Current

Links

JP2024538285A 2021-12-23 2022-12-23 ナノ粒子、及び核酸の封入のための製造方法 Pending JP2025501764A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163293497P 2021-12-23 2021-12-23
US63/293,497 2021-12-23
US202263314364P 2022-02-25 2022-02-25
US63/314,364 2022-02-25
US202263389349P 2022-07-14 2022-07-14
US63/389,349 2022-07-14
PCT/US2022/053948 WO2023122331A2 (en) 2021-12-23 2022-12-23 Nanoparticles and methods of production for the encapsulation of nucleic acids

Publications (2)

Publication Number Publication Date
JP2025501764A JP2025501764A (ja) 2025-01-23
JP2025501764A5 true JP2025501764A5 (enExample) 2026-01-30

Family

ID=86903681

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024538285A Pending JP2025501764A (ja) 2021-12-23 2022-12-23 ナノ粒子、及び核酸の封入のための製造方法

Country Status (6)

Country Link
US (1) US20250057780A1 (enExample)
EP (1) EP4452229A4 (enExample)
JP (1) JP2025501764A (enExample)
AU (1) AU2022419468A1 (enExample)
CA (1) CA3241414A1 (enExample)
WO (1) WO2023122331A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117363135B (zh) * 2023-11-01 2024-05-17 常熟理工学院 一种氢键粘结的改性有机硅海洋防污涂料
CN118147231B (zh) * 2024-05-11 2024-07-12 北京大学 包含工程化转运核糖核酸分子的核酸构建体及其应用
WO2026053147A1 (en) * 2024-09-05 2026-03-12 Sanofi Pasteur Inc. Helper lipids and lnp compositions comprising same
WO2026106695A1 (en) * 2024-11-13 2026-05-21 Optimeos Life Sciences, Inc. Targeted nanoparticles encapsulating water-soluble therapeutics, methods of production, and use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2185626A4 (en) * 2007-08-23 2010-09-08 Medivas Llc BIODEGRADABLE POLYMERIC GENE TRANSFER COMPOSITIONS CONTAINING CATIONIC ALPHA-AMINO ACIDS
WO2012031205A2 (en) * 2010-09-03 2012-03-08 The Brigham And Women's Hospital, Inc. Lipid-polymer hybrid particles
PT3682905T (pt) * 2011-10-03 2022-04-07 Modernatx Inc Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações
WO2015200054A2 (en) * 2014-06-24 2015-12-30 The Trustees Of Princeton University Process for encapsulating soluble biologics, therapeutics, and imaging agents
US11253598B2 (en) * 2015-09-15 2022-02-22 Samyang Holdings Corporation Pharmaceutical composition containing anionic drug, and preparation method therefor
HRP20220156T1 (hr) * 2015-09-17 2022-04-15 Modernatx, Inc. Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
WO2017112828A1 (en) * 2015-12-22 2017-06-29 The Trustees Of Princeton University Process for encapsulating soluble biologics, therapeutics, and imaging agents
JP2021501753A (ja) * 2017-11-03 2021-01-21 ザ・トラスティーズ・オブ・プリンストン・ユニバーシティＴｈｅ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｐｒｉｎｃｅｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ 徐放性ナノキャリア製剤を形成するための疎水性イオン対化およびフラッシュナノ沈殿
US11731099B2 (en) * 2018-07-20 2023-08-22 The Trustees Of Princeton University Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation
US12090235B2 (en) * 2018-09-20 2024-09-17 Modernatx, Inc. Preparation of lipid nanoparticles and methods of administration thereof
WO2021046078A1 (en) * 2019-09-04 2021-03-11 The Trustees Of Princeton University Comb polymer and block copolymer stabilized nanoparticles encapsulating nucleic acids and other soluble hydrophilic compounds
US11648211B2 (en) * 2019-09-23 2023-05-16 Northeastern University Nanoencapsulated combination drug formulations
US11241493B2 (en) * 2020-02-04 2022-02-08 Curevac Ag Coronavirus vaccine

Similar Documents

Publication Publication Date Title
US20230158126A1 (en) Rna for treatment or prophylaxis of a liver disease
US12528855B2 (en) KRAS variant mRNA molecules
US9415109B2 (en) Stable non-aggregating nucleic acid lipid particle formulations
US11191849B2 (en) Compositions and methods for delivering messenger RNA
EP3100718B1 (en) Improved compositions and methods for the delivery of nucleic acids
JP6620093B2 (ja) メッセンジャーｒｎａを送達するための組成物及び方法
US10626393B2 (en) Delivering CRISPR therapeutics with lipid nanoparticles
JP2011507534A5 (enExample)
US20240409954A1 (en) Gene construct for expressing mrna
EP4373946A1 (en) Method of enhancing gene therapy by targeting cgas-sting pathway
JP2024535766A5 (enExample)
JP2024534066A5 (enExample)
KR20250147284A (ko) 진세노사이드 또는 이의 유도체를 포함하는 지질나노입자 및 이의 용도
US20250221932A1 (en) Immune enhancement of cancer treatment
WO2023144193A1 (en) Mrnas for treatment of hereditary tyrosinemia type i
KR20250064736A (ko) 방광암 예방 또는 치료용 조성물
EP4722368A1 (en) Novel nucleic acid construct comprising poly(a) tail having secondary or tertiary structure and uses thereof